Exagen Inc. revised revenue guidance for the first quarter of 2023. The company provided first quarter of 2023 revenue guidance of $8.2 million to $9.2 million. The strong momentum seen in fourth quarter of 2022 have continued and the company increasing revenue guidance to a range of $9.2 million to $9.7 million.